42.0.0.26 – Redirect Fix (Removed pre-redirect output)
DEBUG LOG – klik om te openen
=== VARIABELEN ===
Array
(
[defid] => VWS-WOO-08b-1495028
[request_id] =>
)
=== SQL LOG ===
Geen SQL queries.
Huidig document record
Array
(
[id] => f70a1765-989c-4ec6-ac21-deca4f594a95
[Document ID] => 1495028
[Document naam] => RE MSSG - list of critical medicines for COVID-19 - comment NL.eml
[Bestandsnaam] =>
[Beoordeling] =>
[Beoordelingsgrond] =>
[Toelichting] =>
[Publieke link] =>
[Locatie open.minvws.nl] => https://open.minvws.nl/dossier/VWS-WOO/3811862-1064852-pdo/document/VWS-WOO-08b-1495028
[Opgeschort] =>
[Definitief ID] => VWS-WOO-08b-1495028
[Status] => shiningstar
[FromFile] => https://open.minvws.nl/dossier/VWS-WOO/3811862-1064852-pdo
[DocumentPublicationDate] => 7 juni 2022
[DocumentStatusCheckedDate] => 2026-04-29 12:18:38.259555
[DocumentStatusCheckedResult] => 200
[SourceFileType] =>
[Tags] =>
[Besluit] =>
[ModifiedDate] => 2025-09-22 10:24:22
[DeletedDate] =>
[BesluitURL] =>
[CreatedDate] => 2025-06-19 18:31:59
[DocumentDownloadLink] =>
[DigestLaatsteControleDatum] => 2025-09-22 10:24:22
)
Document: VWS-WOO-08b-1495028
Klik om te vergroten
Document correcties
Geregistreerde datum: 20220607
Geregistreerde documentnaam: RE MSSG - list of critical medicines for COVID-19 - comment NL.eml
Document attributen
| Tag | Waarde | Datum |
|---|---|---|
| Request_Onderdeel van | Woo-deelbesluit aangaande Vaccinaties en Medicatie over EMA Communicatie | 2025-08-01 16:59:58 |
| Request_Periode | December 2019 t/m juni 2022 | 2025-08-01 16:59:58 |
| Request_Onderdeel van_linkname_1 | Woo-deelbesluit aangaande Vaccinaties en Medicatie over EMA Communicatie | 2025-08-01 16:59:58 |
| document_SectionDownloadButton | 1 | 2025-08-01 16:59:58 |
| About_Gelakte gegevens | 5.1.2e Eerbiediging van de persoonlijke levenssfeer 5.1.5 Het voorkomen van onevenredige benadeling Komt u in dit document gegevens tegen waarvan u denkt dat deze gelakt hadden moeten worden? Of is het document slecht leesbaar? Laat het ons weten | 2025-08-01 16:59:58 |
| About_Gelakte gegevens_linkhref_3 | mailto:_dienstpostbusWoo-corona-ondersteuning@minvws.nl | 2025-08-01 16:59:58 |
| Request_Omvang openbaarmaking_linkname_1 | Inventarislijst | 2025-06-30 06:27:30 |
| Request_Omvang openbaarmaking_documenten | 4 | 2025-06-30 06:27:30 |
| Request_Omvang openbaarmaking_paginas | 10 | 2025-06-30 06:27:30 |
| Request_Omvang openbaarmaking_linkhref_1 | https://open.minvws.nl/dossier/VWS-WOO/3811862-1064852-pdo/file/download/inventory | 2025-06-30 06:27:30 |
| Request_Periode | Alles | 2025-06-30 06:27:30 |
| document_documentName | RE MSSG - list of critical medicines for COVID-19 - comment NL.eml | 2025-06-30 06:27:30 |
| document_documentType | E-mailbericht | 2025-06-30 06:27:30 |
| document_documentPublicationDate | 2022-06-07 | 2025-06-30 06:27:30 |
| document_documentNumber | VWS-WOO-08b-1495028 | 2025-06-30 06:27:30 |
| document_SectionDownloadButton | 0 | 2025-06-30 06:27:30 |
| document_SectionHTMLDataDivs | 2 | 2025-06-30 06:27:30 |
| document_SectionAbout | 1 | 2025-06-30 06:27:30 |
| About_Datum document | 7 juni 2022 | 2025-06-30 06:27:30 |
| About_Type bronbestand | E-mailbericht, 3 pagina's | 2025-06-30 06:27:30 |
| About_Type bronbestand_paginas | 3 | 2025-06-30 06:27:30 |
| About_Download als | PDF (1.53 MB) | 2025-06-30 06:27:30 |
| About_Documentnummer | 1495028 | 2025-06-30 06:27:30 |
| About_Beoordeling | Gedeeltelijke openbaarmaking | 2025-06-30 06:27:30 |
| About_Gelakte gegevens | 5.1.2e Eerbiediging van de persoonlijke levenssfeer 5.1.5 Het voorkomen van onevenredige benadeling Komt u in dit document gegevens tegen waarvan u denkt dat deze gelakt hadden moeten worden? Of is het document slecht leesbaar? Laat het ons weten. | 2025-06-30 06:27:30 |
| About_Gelakte gegevens_linkhref_1 | https://wetten.overheid.nl/BWBR0045754/2022-08-01#Hoofdstuk5 | 2025-06-30 06:27:30 |
| About_Gelakte gegevens_linkname_1 | 5.1.2e Eerbiediging van de persoonlijke levenssfeer | 2025-06-30 06:27:30 |
| About_Gelakte gegevens_linkhref_2 | https://wetten.overheid.nl/BWBR0045754/2022-08-01#Hoofdstuk5 | 2025-06-30 06:27:30 |
| About_Gelakte gegevens_linkname_2 | 5.1.5 Het voorkomen van onevenredige benadeling | 2025-06-30 06:27:30 |
| About_Gelakte gegevens_linkhref_3 | mailto:_dienstpostbusWoo-corona-ondersteuning@minvws.nl?subject=Opmerking over RE MSSG - list of critical medicines for COVID-19 - comment NL.eml (documentnummer 1ef1dbaa-2bd7-6e44-be81-3d7c43281656) | 2025-06-30 06:27:30 |
| About_Gelakte gegevens_linkname_3 | Laat het ons weten | 2025-06-30 06:27:30 |
| document_SectionRequest | 1 | 2025-06-30 06:27:30 |
| Request_Onderdeel van | Woo-deelbesluit aangaande Vaccinatie & Medicatie over EMA Communicatie. | 2025-06-30 06:27:30 |
| Request_Onderdeel van_linkhref_1 | https://open.minvws.nl/dossier/VWS-WOO/3811862-1064852-pdo | 2025-06-30 06:27:30 |
| Request_Onderdeel van_linkname_1 | Woo-deelbesluit aangaande Vaccinatie & Medicatie over EMA Communicatie. | 2025-06-30 06:27:30 |
| Request_Samenvatting verzoek | De minister van Volksgezondheid, Welzijn en Sport heeft op 23 mei 2024 een besluit genomen op verzoeken in het kader van de Wet open overheid. Het besluit betreft openbaarmaking van documenten die betrekking hebben op informatie aangaande Vaccinatie & Medicatie over EMA Communicatie. | 2025-06-30 06:27:30 |
| Request_Type besluit | Woo-besluit | 2025-06-30 06:27:30 |
| Request_Datum besluit | 23 mei 2024 | 2025-06-30 06:27:30 |
| Request_Omvang openbaarmaking | 4 documenten, 10 pagina's Inventarislijst | 2025-06-30 06:27:30 |
| DocumentDownload_proposed_filename (lokale kopie) | VWS-WOO-08b-1495028.pdf | 2025-04-19 19:56:32 |
| DocumentDownload_linkhref | https://open.minvws.nl/dossier/VWS-WOO/3811862-1064852-pdo/file/download/document/1ef1dbaa-2bd7-6e44-be81-3d7c43281656 | 2025-04-19 19:56:32 |
| DocumentDownload_linkname | Download (pdf, 1.53 MB) | 2025-04-19 19:56:32 |
Archiefversies (4 rijen)
Archiefrij 1 — 2025-09-07 17:17:55
fromFile: folder_import
fromFilePath: /volume3/websites/openrijksoverheid/documenten_files/VWS-WOO-08b-1495028.pdf
documentName: VWS-WOO-08b-1495028.pdf
documentType: pdf
documentCompressedSize: 0
documentSize: 1609267
documentCompressRatio: 0
documentDateModified: 2025-09-07 22:00:41
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-09-07 17:17:55
lastSeen: 2025-09-07 22:00:41
text: 1495028
5.1.2e
@cbg-meb.nl;
) @minvws.nl];!
@ema.europa.eu]
Tue 6/7/2022 11:46:16 AM
Subject: RE:MSSG-listofcritical medicines forCOVID-19-comment NL
Received:Tue 6/7/2022 11:46:43 AM
Thank you very much foryour email and submitting the two additional comments onthe listofcritical medicines forCOVID...
noTextDate: leeg!
ocrText: leeg!
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: leeg!
documentMailAdresses: leeg!
digestSHA256: 746852412c70caa56ee1b0788a0e25a0a5359f1a7692c37824498112f87798b2
documentDate: leeg!
ModifiedDate: 2025-12-10 19:42:20.178639+00
Id: folder_import_3568_3f2c67c4c0b0661c7007a868c3def392
textDigestSHA256: cb0383c91bb5f2bbdc80020143c61a467a351584bcf9c1481e9a75f1958f5de4
ocrTextDigestSHA256: leeg!
extractedId: VWS-WOO-08b-1495028
Archiefrij 2 — 2025-09-04 16:33:02
fromFile: VWS-WOO-3811862-1064852-pdo-1f026c98-b94f-6382-b00b-65673e0af118.zip
fromFilePath: ../../archieven_files/VWS-WOO-3811862-1064852-pdo-1f026c98-b94f-6382-b00b-65673e0af118.zip
documentName: VWS-WOO-08b-1495028.pdf
documentType: pdf
documentCompressedSize: 1199756
documentSize: 1609267
documentCompressRatio: 74.55294864059226
documentDateModified: 2025-05-01 20:37:18
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-09-04 16:33:02
lastSeen: 2025-09-04 16:33:02
text: 1495028
5.1.2e
@cbg-meb.nl;
) @minvws.nl];!
@ema.europa.eu]
Tue 6/7/2022 11:46:16 AM
Subject: RE:MSSG-listofcritical medicines forCOVID-19-comment NL
Received:Tue 6/7/2022 11:46:43 AM
Thank you very much foryour email and submitting the two additional comments onthe listofcritical medicines forCOVID...
noTextDate: leeg!
ocrText: leeg!
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: leeg!
documentMailAdresses: leeg!
digestSHA256: 746852412c70caa56ee1b0788a0e25a0a5359f1a7692c37824498112f87798b2
documentDate: leeg!
ModifiedDate: 2025-12-10 19:42:10.749631+00
Id: VWS-WOO-3811862-1064852-pdo-1f026c98-b94f-6382-b00b-65673e0af118.zip_4
textDigestSHA256: cb0383c91bb5f2bbdc80020143c61a467a351584bcf9c1481e9a75f1958f5de4
ocrTextDigestSHA256: leeg!
extractedId: VWS-WOO-08b-1495028
Archiefrij 3 — 2025-02-27 09:25:08
fromFile: Testverzoek-VWS-WOO-3811862-1064852-pdo.zip
fromFilePath: Z:\ARCHIEF WOO Documenten\archieven_files\Testverzoek-VWS-WOO-3811862-1064852-pdo.zip
documentName: VWS-WOO-08b-1495028-RE_MSSG_-_list_of_critical_medicines_for_COVID-19_-_comment_NL.eml.pdf
documentType: pdf
documentCompressedSize: 1197154
documentSize: 1609267
documentCompressRatio: 74.3912601202908
documentDateModified: 2024-06-06 13:14:08
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-02-27 09:25:08
lastSeen: 2025-02-27 09:25:08
text: 1495028
5.1.2e
@cbg-meb.nl;
) @minvws.nl];!
@ema.europa.eu]
Tue 6/7/2022 11:46:16 AM
Subject: RE:MSSG-listofcritical medicines forCOVID-19-comment NL
Received:Tue 6/7/2022 11:46:43 AM
Thank you very much foryour email and submitting the two additional comments onthe listofcritical medicines forCOVID...
noTextDate: leeg!
ocrText: leeg!
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: [{"position": 15, "email": "@cbg-meb.nl", "context": "1495028 5.1.2e @cbg-meb.nl; ) @minvws.nl];! @ema.europa.eu]"}, {"position": 30, "email": "@minvws.nl", "context": "5.1.2e @cbg-meb.nl; ) @minvws.nl];! @ema.europa.eu] Tue 6/7/2022"}, {"position": 44, "email": "@ema.europa.eu", "context": "@cbg-meb.nl; ) @minvws.nl];! @ema.europa.eu] Tue 6/7/2022 11:46:16"}, {"position": 895, "email": "HLN@cbg-meb.nl", "context": "2022 11:18 5. <HLN@cbg-meb.nl>; @cbg-meb.nl>; 5.1.2e Subject:"}, {"position": 912, "email": "@cbg-meb.nl", "context": "11:18 5. <HLN@cbg-meb.nl>; @cbg-meb.nl>; 5.1.2e Subject: RE:MSSG-listofcritical"}, {"position": 2499, "email": "@ema.europa.eu", "context": "Vane < 5.1.2e @ema.europa.eu> Verzonden: vrijdag 27mei"}, {"position": 2563, "email": "@chg-meb.nl", "context": "10:20 Aan: 5.1.2e @chg-meb.nl>; Onderwerp: RE:MSSG-listofcritical medicines"}, {"position": 3798, "email": "@cma.curopa.eu", "context": "secretariat viaemail to[JERE @cma.curopa.eu. 2.)The comments will"}, {"position": 4453, "email": "@ema.europa.eu", "context": "Telephone 5.1.2e 5.1.2e @ema.europa.eu |www.ema.europa.eu |Fordirections, see"}]
documentMailAdresses: [{"position": 15, "email": "@cbg-meb.nl", "context": "1495028 5.1.2e @cbg-meb.nl; ) @minvws.nl];! @ema.europa.eu]"}, {"position": 30, "email": "@minvws.nl", "context": "5.1.2e @cbg-meb.nl; ) @minvws.nl];! @ema.europa.eu] Tue 6/7/2022"}, {"position": 44, "email": "@ema.europa.eu", "context": "@cbg-meb.nl; ) @minvws.nl];! @ema.europa.eu] Tue 6/7/2022 11:46:16"}, {"position": 895, "email": "HLN@cbg-meb.nl", "context": "2022 11:18 5. <HLN@cbg-meb.nl>; @cbg-meb.nl>; 5.1.2e Subject:"}, {"position": 912, "email": "@cbg-meb.nl", "context": "11:18 5. <HLN@cbg-meb.nl>; @cbg-meb.nl>; 5.1.2e Subject: RE:MSSG-listofcritical"}, {"position": 2499, "email": "@ema.europa.eu", "context": "Vane < 5.1.2e @ema.europa.eu> Verzonden: vrijdag 27mei"}, {"position": 2563, "email": "@chg-meb.nl", "context": "10:20 Aan: 5.1.2e @chg-meb.nl>; Onderwerp: RE:MSSG-listofcritical medicines"}, {"position": 3798, "email": "@cma.curopa.eu", "context": "secretariat viaemail to[JERE @cma.curopa.eu. 2.)The comments will"}, {"position": 4453, "email": "@ema.europa.eu", "context": "Telephone 5.1.2e 5.1.2e @ema.europa.eu |www.ema.europa.eu |Fordirections, see"}]
digestSHA256: cb0383c91bb5f2bbdc80020143c61a467a351584bcf9c1481e9a75f1958f5de4
documentDate: 2022-06-07
ModifiedDate: 2025-12-10 19:41:04.555019+00
Id: 289300
textDigestSHA256: cb0383c91bb5f2bbdc80020143c61a467a351584bcf9c1481e9a75f1958f5de4
ocrTextDigestSHA256: leeg!
extractedId: VWS-WOO-08b-1495028
Archiefrij 4 — 2025-02-18 12:18:02
fromFile: besluit-3811862-1064852-pdo-d2f36210708ed317db87168cd991765ea9aed2aa8095afb8a8e13389345adf55.zip
fromFilePath: Z:\ARCHIEF WOO Documenten\archieven_files\besluit-3811862-1064852-pdo-d2f36210708ed317db87168cd991765ea9aed2aa8095afb8a8e13389345adf55.zip
documentName: VWS-WOO-08b-1495028-RE_MSSG_-_list_of_critical_medicines_for_COVID-19_-_comment_NL.eml.pdf
documentType: pdf
documentCompressedSize: 1197154
documentSize: 1609267
documentCompressRatio: 74.3912601202908
documentDateModified: 2024-06-06 13:14:08
dossierReference: 3811862
dossierReferenceAlias: leeg!
createdDate: 2025-02-18 12:18:02
lastSeen: 2025-02-18 12:18:02
text: 1495028
5.1.2e
@cbg-meb.nl;
) @minvws.nl];!
@ema.europa.eu]
Tue 6/7/2022 11:46:16 AM
Subject: RE:MSSG-listofcritical medicines forCOVID-19-comment NL
Received:Tue 6/7/2022 11:46:43 AM
Thank you very much foryour email and submitting the two additional comments onthe listofcritical medicines forCOVID...
noTextDate: leeg!
ocrText: leeg!
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: [{"position": 15, "email": "@cbg-meb.nl", "context": "1495028 5.1.2e @cbg-meb.nl; ) @minvws.nl];! @ema.europa.eu]"}, {"position": 30, "email": "@minvws.nl", "context": "5.1.2e @cbg-meb.nl; ) @minvws.nl];! @ema.europa.eu] Tue 6/7/2022"}, {"position": 44, "email": "@ema.europa.eu", "context": "@cbg-meb.nl; ) @minvws.nl];! @ema.europa.eu] Tue 6/7/2022 11:46:16"}, {"position": 895, "email": "HLN@cbg-meb.nl", "context": "2022 11:18 5. <HLN@cbg-meb.nl>; @cbg-meb.nl>; 5.1.2e Subject:"}, {"position": 912, "email": "@cbg-meb.nl", "context": "11:18 5. <HLN@cbg-meb.nl>; @cbg-meb.nl>; 5.1.2e Subject: RE:MSSG-listofcritical"}, {"position": 2499, "email": "@ema.europa.eu", "context": "Vane < 5.1.2e @ema.europa.eu> Verzonden: vrijdag 27mei"}, {"position": 2563, "email": "@chg-meb.nl", "context": "10:20 Aan: 5.1.2e @chg-meb.nl>; Onderwerp: RE:MSSG-listofcritical medicines"}, {"position": 3798, "email": "@cma.curopa.eu", "context": "secretariat viaemail to[JERE @cma.curopa.eu. 2.)The comments will"}, {"position": 4453, "email": "@ema.europa.eu", "context": "Telephone 5.1.2e 5.1.2e @ema.europa.eu |www.ema.europa.eu |Fordirections, see"}]
documentMailAdresses: [{"position": 15, "email": "@cbg-meb.nl", "context": "1495028 5.1.2e @cbg-meb.nl; ) @minvws.nl];! @ema.europa.eu]"}, {"position": 30, "email": "@minvws.nl", "context": "5.1.2e @cbg-meb.nl; ) @minvws.nl];! @ema.europa.eu] Tue 6/7/2022"}, {"position": 44, "email": "@ema.europa.eu", "context": "@cbg-meb.nl; ) @minvws.nl];! @ema.europa.eu] Tue 6/7/2022 11:46:16"}, {"position": 895, "email": "HLN@cbg-meb.nl", "context": "2022 11:18 5. <HLN@cbg-meb.nl>; @cbg-meb.nl>; 5.1.2e Subject:"}, {"position": 912, "email": "@cbg-meb.nl", "context": "11:18 5. <HLN@cbg-meb.nl>; @cbg-meb.nl>; 5.1.2e Subject: RE:MSSG-listofcritical"}, {"position": 2499, "email": "@ema.europa.eu", "context": "Vane < 5.1.2e @ema.europa.eu> Verzonden: vrijdag 27mei"}, {"position": 2563, "email": "@chg-meb.nl", "context": "10:20 Aan: 5.1.2e @chg-meb.nl>; Onderwerp: RE:MSSG-listofcritical medicines"}, {"position": 3798, "email": "@cma.curopa.eu", "context": "secretariat viaemail to[JERE @cma.curopa.eu. 2.)The comments will"}, {"position": 4453, "email": "@ema.europa.eu", "context": "Telephone 5.1.2e 5.1.2e @ema.europa.eu |www.ema.europa.eu |Fordirections, see"}]
digestSHA256: cb0383c91bb5f2bbdc80020143c61a467a351584bcf9c1481e9a75f1958f5de4
documentDate: 2022-06-07
ModifiedDate: 2025-12-10 19:42:20.178639+00
Id: 29344
textDigestSHA256: cb0383c91bb5f2bbdc80020143c61a467a351584bcf9c1481e9a75f1958f5de4
ocrTextDigestSHA256: leeg!
extractedId: VWS-WOO-08b-1495028
(dit is ook een speeltuin)